Cost-Effectiveness Analysis of Ticagrelor Compared to Clopidogrel for the Treatment of Patients With Acute Coronary Syndrome in Colombia

ABSTRACT: Introduction: Acute coronary syndrome is one of the most frequent medical emergencies in developing countries.Objective: To determine, from the perspective of the Colombian health system, the cost-effectiveness of ticagrelor compared to clopidogrel for the treatment of patients with acute coronary syndrome. Materials and methods: We conducted a cost-effectiveness analysis from the perspective of the Colombian health system comparing ticagrelor and clopidogrel for the treatment of patients with acute coronary syndrome. To estimate the expected costs and outcomes, a Markov model was constructed in which patients could remain stable without experiencing new cardiovascular events, suffer from a new event, or die. For the baseline case, a 10-year time horizon and a discount ratio of 3% for costs and benefits were adopted. The transition probabilities were extracted from the PLATO (Platelet Inhibition and Patient Outcomes) clinical trial. Vital statistics were drawn from the Departmento Administrativo Nacional de Estadística (DANE) and additional information from Colombian patients included in the Access registry. To identify and measure resource use, a standard case was built by consulting guidelines and protocols. Unit costs were obtained from Colombian rate lists. A probabilistic sensitivity analysis was conducted in which costs were represented by a triangular distribution, and the effectiveness through a beta distribution.Results: In the base case, the additional cost per quality-adjusted life-year gained with ticagrelor was COP$ 28,411,503. The results were sensitive to changes in the time horizon and the unit cost of clopidogrel. For a willingness-to-pay equivalent to three times the Colombian per capita gross domestic product, the probability of ticagrelor being cost-effective was 75%. Conclusions: Ticagrelor is a cost-effective strategy for the treatment of patients with acute coronary syndrome in Colombia

• Autores: Mejía Mejía, Aurelio Enrique; Senior Sánchez, Juan Manuel; Ceballos González, Mateo; Atehortúa Becerra, Sara Catalina; Toro Escobar, Juan Manuel; Saldarriaga Giraldo, Clara Inés; Mejía Pascuales, María Elena; Ramírez Zuluaga, Carolina María
• Tipo de recurso: Article of investigation
• Fecha de publicación: 2015
• Institución: Universidad de Antioquia
• Repositorio: Repositorio UdeA
• Idioma: eng
• OAI Identifier: oai:bibliotecadigital.udea.edu.co:10495/31708
• Acceso en línea: https://hdl.handle.net/10495/31708
• Palabra clave: Costos y Análisis de Costo; Costs and Cost Analysis; Economía médica; Economics, Medical; Estudios de Evaluación como Asunto; Evaluation Studies as Topic; Síndrome coronario agudo; Acute Coronary Syndrome; Economía de la salud; Health economics
• Rights: openAccess
• License: https://creativecommons.org/licenses/by-nc-nd/4.0/